105 related articles for article (PubMed ID: 38808744)
1. The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: IV-consensus guidelines for the management of post-transplant lymphoproliferative disorders in children and adolescents.
Allen UD; L'Huillier AG; Bollard CM; Gross TG; Hayashi RJ; Höcker B; Maecker-Kolhoff B; Marks SD; Mazariegos GV; Smets F; Trappe RU; Visner G; Chinnock RE; Comoli P; Danziger-Isakov L; Dulek DE; Dipchand AI; Ferry JA; Martinez OM; Metes DM; Michaels MG; Preiksaitis J; Squires JE; Swerdlow SH; Wilkinson JD; Dharnidharka VR; Green M; Webber SA; Esquivel CO
Pediatr Transplant; 2024 Aug; 28(5):e14781. PubMed ID: 38808744
[TBL] [Abstract][Full Text] [Related]
2. The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III - Consensus guidelines for Epstein-Barr virus load and other biomarker monitoring.
Preiksaitis J; Allen U; Bollard CM; Dharnidharka VR; Dulek DE; Green M; Martinez OM; Metes DM; Michaels MG; Smets F; Chinnock RE; Comoli P; Danziger-Isakov L; Dipchand AI; Esquivel CO; Ferry JA; Gross TG; Hayashi RJ; Höcker B; L'Huillier AG; Marks SD; Mazariegos GV; Squires J; Swerdlow SH; Trappe RU; Visner G; Webber SA; Wilkinson JD; Maecker-Kolhoff B
Pediatr Transplant; 2024 Feb; 28(1):e14471. PubMed ID: 37294621
[TBL] [Abstract][Full Text] [Related]
3. The IPTA Nashville consensus conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: II-consensus guidelines for prevention.
Green M; Squires JE; Chinnock RE; Comoli P; Danziger-Isakov L; Dulek DE; Esquivel CO; Höcker B; L'Huillier AG; Mazariegos GV; Visner GA; Bollard CM; Dipchand AI; Ferry JA; Gross TG; Hayashi R; Maecker-Kolhoff B; Marks S; Martinez OM; Metes DM; Michaels MG; Preiksaitis J; Smets F; Swerdlow SH; Trappe RU; Wilkinson JD; Allen U; Webber SA; Dharnidharka VR
Pediatr Transplant; 2024 Feb; 28(1):e14350. PubMed ID: 36369745
[TBL] [Abstract][Full Text] [Related]
4. The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: I-Methodology for the development of consensus practice guidelines.
Wilkinson JD; Allen U; Green M; Dipchand AI; Dharnidharka VR; Esquivel CO; Maecker-Kolhoff B; Preiksaitis J; Swerdlow SH; Webber SA;
Pediatr Transplant; 2024 Feb; 28(1):e14333. PubMed ID: 36369733
[TBL] [Abstract][Full Text] [Related]
5. A multicenter survey on post-transplant lymphoproliferative disorders in pediatric heart transplant recipients: A case for development of consensus guidelines for screening, surveillance, and treatment?
Weisert M; Harake D; Hede S; Russell M; Alejos J; Menteer J
Pediatr Transplant; 2020 Aug; 24(5):e13730. PubMed ID: 32416037
[TBL] [Abstract][Full Text] [Related]
6. Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: Single-center experience.
Devine K; Ranganathan S; Mazariegos G; Bond G; Soltys K; Ganoza A; Sun Q; Sindhi R
Pediatr Transplant; 2020 Aug; 24(5):e13723. PubMed ID: 32424963
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Allen UD; Preiksaitis JK;
Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
[TBL] [Abstract][Full Text] [Related]
8. A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines.
Yamada M; L'Huillier AG; Green M
J Pediatric Infect Dis Soc; 2024 Feb; 13(Supplement_1):S31-S38. PubMed ID: 38417085
[TBL] [Abstract][Full Text] [Related]
9. Presentation and outcomes of post-transplant lymphoproliferative disorder at a single institution pediatric transplant center.
Ramos-Gonzalez G; Crum R; Allain A; Agur T; O'Melia L; Staffa S; Burchett SK; Siegele B; Weinberg O; Rodig NM; Fawaz R; Singh TP; Freiberger DA; Bae Kim H
Pediatr Transplant; 2022 Aug; 26(5):e14268. PubMed ID: 35304794
[TBL] [Abstract][Full Text] [Related]
10. Post-transplant lymphoproliferative disorder of the pediatric airway: Presentation and management.
O'Neill AF; Adil EA; Irace AL; Neff L; Davis IJ; Perez-Atayde AR; Voss SD; Weinberg O; Rahbar R
Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():218-23. PubMed ID: 27260610
[TBL] [Abstract][Full Text] [Related]
11. Management of post-transplant lymphoproliferative disorders.
Llaurador G; McLaughlin L; Wistinghausen B
Curr Opin Pediatr; 2017 Feb; 29(1):34-40. PubMed ID: 27906865
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults.
Rubinstein J; Toner K; Gross T; Wistinghausen B
Best Pract Res Clin Haematol; 2023 Mar; 36(1):101446. PubMed ID: 36907642
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
[TBL] [Abstract][Full Text] [Related]
14. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.
Afify ZAM; Taj MM; Orjuela-Grimm M; Srivatsa K; Miller TP; Edington HJ; Dalal M; Robles J; Ford JB; Ehrhardt MJ; Ureda TJ; Rubinstein JD; McCormack S; Rivers JM; Chisholm KM; Kavanaugh MK; Bukowinski AJ; Friehling ED; Ford MC; Reddy SN; Marks LJ; Smith CM; Mason CC
Cancer; 2023 Mar; 129(5):780-789. PubMed ID: 36571557
[TBL] [Abstract][Full Text] [Related]
15. Posttransplant lymphoproliferative disease after pediatric solid organ transplantation.
Mynarek M; Schober T; Behrends U; Maecker-Kolhoff B
Clin Dev Immunol; 2013; 2013():814973. PubMed ID: 24174972
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients.
Berney T; Delis S; Kato T; Nishida S; Mittal NK; Madariaga J; Levi D; Nery JR; Cirocco RE; Gelman B; Ruiz P; Tzakis AG
Transplantation; 2002 Oct; 74(7):1000-6. PubMed ID: 12394845
[TBL] [Abstract][Full Text] [Related]
17. [Post-transplantation lymphoproliferative disorder in childhood].
Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States.
Tajima T; Martinez OM; Bernstein D; Boyd SD; Gratzinger D; Lum G; Sasaki K; Tan B; Twist CJ; Weinberg K; Armstrong B; Desai DM; Mazariegos GV; Chin C; Fishbein TM; Tekin A; Venick RS; Krams SM; Esquivel CO
Pediatr Transplant; 2024 Jun; 28(4):e14763. PubMed ID: 38682750
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant lymphoproliferative disorder after solid-organ transplant in children.
Absalon MJ; Khoury RA; Phillips CL
Semin Pediatr Surg; 2017 Aug; 26(4):257-266. PubMed ID: 28964482
[TBL] [Abstract][Full Text] [Related]
20. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
Ganne V; Siddiqi N; Kamaplath B; Chang CC; Cohen EP; Bresnahan BA; Hariharan S
Clin Transplant; 2003 Oct; 17(5):417-22. PubMed ID: 14703923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
